Pneumocystis jirovecii pneumonia medical therapy: Difference between revisions
No edit summary |
|||
| Line 18: | Line 18: | ||
*Pneumocystis jirovecii pneumonia | *Pneumocystis jirovecii pneumonia | ||
:*Preventing First Episode of PCP (Primary Prophylaxis) | :*'''1. Preventing First Episode of PCP (Primary Prophylaxis)''' | ||
::*Preferred regimen: [[TMP-SMX]] 1 Double-Strength(DS) PO daily {{or}} [[TMP-SMX]] 1 Single-Strength(SS) PO daily | ::*Preferred regimen: [[TMP-SMX]] 1 Double-Strength(DS) PO daily {{or}} [[TMP-SMX]] 1 Single-Strength(SS) PO daily | ||
::*Alternative regimen(1): [[TMP-SMX]] 1 Double-Strength(DS) tid weekly {{or}} [[Dapsone]] 100 mg PO daily or 50 mg PO BID | |||
::*Alternative regimen(2): [[Dapsone]] 50 mg PO daily {{and}} ([[Pyrimethamine]] 50 mg + [[Leucovorin]] 25 mg) PO weekly | |||
::*Alternative regimen(3): [[Dapsone]] 200 mg {{and}} [[Pyrimethamine]] 75 mg {{and}} [[Leucovorin]] 25 mg PO weekly | |||
::*Alternative regimen(4): Aerosolized [[Pentamidinec]] 300 mg via Respigard II™ nebulizer every month | |||
::*Alternative regimen(5): [[Atovaquone]] 1500 mg PO daily with food | |||
::*Alternative regimen(6): [[Atovaquone]] 1500 mg {{and}} [[Pyrimethamine]] 25 mg {{and}} [[Leucovorin]] 10 mg PO daily with food | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 15:14, 9 July 2015
|
Pneumocystis jirovecii pneumonia Microchapters |
|
Differentiating Pneumocystis jirovecii pneumonia from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pneumocystis jirovecii pneumonia medical therapy On the Web |
|
American Roentgen Ray Society Images of Pneumocystis jirovecii pneumonia medical therapy |
|
Pneumocystis jirovecii pneumonia medical therapy in the news |
|
Risk calculators and risk factors for Pneumocystis jirovecii pneumonia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Antipneumocystic medication is used with concomitant steroids in order to avoid inflammation, which causes an exacerbation of symptoms about four days after treatment begins if steroids are not used. By far the most commonly used medication is a combination of trimethoprim and sulfamethoxazole (co-trimoxazole, with the tradenames Bactrim, Septrin, or Septra), but some patients are unable to tolerate this treatment due to allergies. Other medications that are used, alone or in combination, include pentamidine, trimetrexate, dapsone, atovaquone, primaquine, and clindamycin. Treatment is usually for a period of about 21 days.
Pentamidine is less often used as its major limitation is the high frequency of side effects. These include acute pancreatitis, renal failure, hepatotoxicity, leukopenia, rash, fever and hypoglycaemia.
Guidelines
To read about guidelines for prevention and treatment of Pneumocystis pneumonia Infections in HIV-Infected Adults and Adolescents, click here.
Antimicrobial Regimen
- Pneumocystis jirovecii pneumonia
- 1. Preventing First Episode of PCP (Primary Prophylaxis)
- Preferred regimen: TMP-SMX 1 Double-Strength(DS) PO daily OR TMP-SMX 1 Single-Strength(SS) PO daily
- Alternative regimen(1): TMP-SMX 1 Double-Strength(DS) tid weekly OR Dapsone 100 mg PO daily or 50 mg PO BID
- Alternative regimen(2): Dapsone 50 mg PO daily AND (Pyrimethamine 50 mg + Leucovorin 25 mg) PO weekly
- Alternative regimen(3): Dapsone 200 mg AND Pyrimethamine 75 mg AND Leucovorin 25 mg PO weekly
- Alternative regimen(4): Aerosolized Pentamidinec 300 mg via Respigard II™ nebulizer every month
- Alternative regimen(5): Atovaquone 1500 mg PO daily with food
- Alternative regimen(6): Atovaquone 1500 mg AND Pyrimethamine 25 mg AND Leucovorin 10 mg PO daily with food